12-123298041-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001167856.3(SBNO1):āc.3976A>Gā(p.Ser1326Gly) variant causes a missense change. The variant allele was found at a frequency of 0.000432 in 1,613,998 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00026 ( 0 hom., cov: 32)
Exomes š: 0.00045 ( 0 hom. )
Consequence
SBNO1
NM_001167856.3 missense
NM_001167856.3 missense
Scores
2
4
13
Clinical Significance
Conservation
PhyloP100: 6.15
Genes affected
SBNO1 (HGNC:22973): (strawberry notch homolog 1) Predicted to enable chromatin DNA binding activity and histone binding activity. Predicted to be involved in regulation of transcription, DNA-templated. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.10274115).
BS2
High AC in GnomAd4 at 39 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SBNO1 | NM_001167856.3 | c.3976A>G | p.Ser1326Gly | missense_variant | 31/32 | ENST00000602398.3 | NP_001161328.1 | |
SBNO1 | NM_018183.5 | c.3973A>G | p.Ser1325Gly | missense_variant | 31/32 | NP_060653.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SBNO1 | ENST00000602398.3 | c.3976A>G | p.Ser1326Gly | missense_variant | 31/32 | 5 | NM_001167856.3 | ENSP00000473665 | P4 | |
SBNO1 | ENST00000420886.6 | c.3976A>G | p.Ser1326Gly | missense_variant | 30/31 | 1 | ENSP00000387361 | P4 | ||
SBNO1 | ENST00000267176.8 | c.3973A>G | p.Ser1325Gly | missense_variant | 31/32 | 5 | ENSP00000267176 | A1 |
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152222Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
39
AN:
152222
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000179 AC: 45AN: 251286Hom.: 0 AF XY: 0.000191 AC XY: 26AN XY: 135834
GnomAD3 exomes
AF:
AC:
45
AN:
251286
Hom.:
AF XY:
AC XY:
26
AN XY:
135834
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000451 AC: 659AN: 1461776Hom.: 0 Cov.: 32 AF XY: 0.000451 AC XY: 328AN XY: 727200
GnomAD4 exome
AF:
AC:
659
AN:
1461776
Hom.:
Cov.:
32
AF XY:
AC XY:
328
AN XY:
727200
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000256 AC: 39AN: 152222Hom.: 0 Cov.: 32 AF XY: 0.000229 AC XY: 17AN XY: 74364
GnomAD4 genome
AF:
AC:
39
AN:
152222
Hom.:
Cov.:
32
AF XY:
AC XY:
17
AN XY:
74364
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
2
ALSPAC
AF:
AC:
5
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
18
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 01, 2024 | The c.3976A>G (p.S1326G) alteration is located in exon 30 (coding exon 30) of the SBNO1 gene. This alteration results from a A to G substitution at nucleotide position 3976, causing the serine (S) at amino acid position 1326 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.;T
Eigen
Benign
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;.
M_CAP
Benign
D
MetaRNN
Benign
T;T;T
MetaSVM
Uncertain
T
MutationAssessor
Benign
L;.;L
MutationTaster
Benign
D;D
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N;.
REVEL
Benign
Sift
Benign
T;T;.
Sift4G
Benign
T;T;T
Polyphen
B;B;B
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at